Belite Bio- Adr logo

Belite Bio- Adr Share Price (NASDAQ: BLTE)

$63.46

-1.05

(-1.63%)

Last updated on

Check the interactive Belite Bio- Adr Stock chart to analyse performance

Belite Bio- Adr stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$63.10
    Today's High:$63.90

    Day's Volatility :1.25%

  • 52 Weeks Low:$43.70
    52 Weeks High:$86.53

    52 Weeks Volatility :49.5%

Belite Bio- Adr Stock Returns

PeriodBelite Bio Inc - AdrSector (Health Care)Index (Russel 2000)
3 Months
-2.95%
3.6%
0.0%
6 Months
10.37%
-7.7%
0.0%
1 Year
30.4%
-12.6%
0.0%
3 Years
71.93%
10.2%
-4.1%

Belite Bio Inc - Adr Key Stats

Check Belite Bio- Adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$64.51
Open
$63.9
Today's High
$63.9
Today's Low
$63.1
Market Capitalization
$2.1B
Today's Volume
$17.2K
52 Week High
$86.53
52 Week Low
$43.7
Revenue TTM
$0.0
EBITDA
$-25.5M
Earnings Per Share (EPS)
$-1.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-17.33%

Stock Returns calculator for Belite Bio- Adr Stock including INR - Dollar returns

The Belite Bio- Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Belite Bio- Adr investment value today

Current value as on today

₹1,36,427

Returns

₹36,427

(+36.43%)

Returns from Belite Bio- Adr Stock

₹31,143 (+31.14%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Belite Bio- Adr Stock

-20%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Belite Bio- Adr Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Belite Bio Inc - Adr

  • Name

    Holdings %

  • State Street Corp

    0.06%

  • Geode Capital Management, LLC

    0.04%

  • Marshall Wace Asset Management Ltd

    0.03%

  • JPMorgan Chase & Co

    0.03%

  • Citadel Advisors Llc

    0.02%

  • Bank of America Corp

    0.02%

Analyst Recommendation on Belite Bio- Adr Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Belite Bio- Adr(by analysts ranked 0 to 5 stars)

Belite Bio- Adr Share Price Target

What analysts predicted

Upside of 47.73%

Target:

$93.75

Current:

$63.46

Belite Bio- Adr share price target is $93.75, a slight Upside of 47.73% compared to current price of $63.46 as per analysts' prediction.

Belite Bio- Adr Stock Insights

  • Price Movement

    In the last 3 years, BLTE stock has moved up by 96.5%
  • BLTE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 40.3%
  • BLTE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 19.5%

Belite Bio- Adr Technicals Summary

Sell

Neutral

Buy

Belite Bio- Adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Belite Bio Inc - Adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Belite Bio Inc - Adr logo
-3.99%
10.37%
30.4%
71.93%
330.72%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Belite Bio Inc - Adr

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an anti-retinol-binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Organization
Belite Bio- Adr
Employees
25
CEO
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Industry
Healthcare

Key Management of Belite Bio Inc - Adr

NameTitle
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Chairman of the Board of Directors & CEO
Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.
CFO & Director
Dr. Nathan L. Mata Ph.D.
Chief Scientific Officer
Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in BLTE Stock from India :

What is Belite Bio- Adr share price today?

Belite Bio- Adr share price today is $63.46 as on at the close of the market. Belite Bio- Adr share today touched a day high of $63.90 and a low of $63.10.

What is the 52 week high and 52 week low for Belite Bio- Adr share?

Belite Bio- Adr share touched a 52 week high of $86.53 and a 52 week low of $43.70. Belite Bio- Adr stock price today i.e. is closed at $63.46, lower by 26.66% versus the 52 week high.

How to invest in Belite Bio- Adr Stock (BLTE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Belite Bio- Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Belite Bio- Adr Shares that will get you 0.0236 shares as per Belite Bio- Adr share price of $63.46 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Belite Bio- Adr Stock (BLTE) from India?

Indian investors can start investing in Belite Bio- Adr (BLTE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Belite Bio- Adr stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Belite Bio- Adr share’s latest price of $63.46 as on August 30, 2025 at 1:29 am IST, you will get 0.1576 shares of Belite Bio- Adr. Learn more about fractional shares .

What are the returns that Belite Bio- Adr has given to Indian investors in the last 5 years?

Belite Bio- Adr stock has given 330.72% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?